Skip to navigation menu Skip to content
Informational Alert

Learn about progress on health equity and anti-racism efforts in Seattle Children’s fourth quarterly report.


  • Matt Biery

    Matt Biery


    Matt earned a B.S. in biology at the University of Oregon and an M.S. in molecular biology at San Diego State University. He is excited to work on generating treatment naïve models for DIPG and other pediatric brain tumors and identifying promising targets and therapies.

  • Alex  Doan

    Alex Doan

    Graduate Student (PhD Candidate)

    Alex earned a BS with honors and a MS in biology at Stanford University and is currently pursuing an MD/PhD through the MSTP program at the University of Washington. He is interested in cancer and immuno-oncology research and is excited to work on identifying novel targets and therapies for pediatric brain tumors. He identifies as first-generation and is also passionate about health and research equity.

  • Michael Meechan, BS

    Michael Meechan, BS


    Michael earned a B.S. in chemistry and minor in music at the University of Washington. He is passionate about preclinical translational research and leads the lab's in vivo studies. Michael investigates novel therapies in patient-derived tumor models of life-threatening pediatric central nervous system tumors with the hope of best informing future clinical trials.

  • Carrie H. Myers

    Carrie H. Myers


    Carrie earned a B.S. in biochemistry at Purdue University. She has a passion for cancer research, focusing on areas ranging from intraoperative, fluorescence-guided imaging for tumor resection to T cell immunotherapy and pediatric brain tumor model development.

  • Sophie Tahiri

    Sophie Tahiri

    Graduate Student (PhD Candidate)

    Sophie earned a B.A. with honors in neurobiology at New College of Florida, a MSc with Distinction in Molecular Medicine and Cancer Research at Brunel University London and is earning a PhD in Molecular Medicine and Mechanisms of Disease at University of Washington. She focuses on CAR T cell therapy for brain tumors.

Join the Team

Contact Dr. Nicholas Vitanza.

By clicking “Accept All Cookies,” you agree to the storing of cookies on your device to enhance site navigation, analyze site usage and assist in marketing efforts. For more information, see Website Privacy.

Accept All Cookies